Actively Recruiting
Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life
Led by Region Västerbotten · Updated on 2026-02-10
300
Participants Needed
1
Research Sites
677 weeks
Total Duration
On this page
Sponsors
R
Region Västerbotten
Lead Sponsor
U
Umeå University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This observational study aims to evaluate routine treatment outcomes in men with lichen sclerosus (LS), including a long-term follow-up to assess disease progression and histopathological changes. The study also investigates potential risk factors for LS and the disease's impact on quality of life and sexual health.
CONDITIONS
Official Title
Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biologically male
- 18 years old or older
- Referred to dermatology or urology in V�e4sterbotten and diagnosed with lichen sclerosus
- Able to read and write Swedish to complete questionnaires and consent
- For control group (urology): Biologically male, 18 years or older, phimosis without LS, treated with circumcision
- For control group (general population): Biologically male with male genitalia, 18 years or older, no genital symptoms, able to read and write Swedish
You will not qualify if you...
- Under 18 years old
- Unable to read and write Swedish
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Umeå University Hospital
Umeå, Sweden
Actively Recruiting
Research Team
M
Maja af Klinteberg, MD, PhD
CONTACT
A
Amir Sherif, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here